Rare Case of Tacrolimus-Induced Acute Pancreatitis in a Liver Transplant Recipient

被引：0

作者：

Prado, Renan ^{[1
]}

Chatterjee, Arjun ^{[2
]}

Zaalishvili, Zurabi ^{[1
]}

Kundu, Rupayan ^{[1
]}

Junna, Shilpa ^{[2
]}

Sengupta, Shreya ^{[2
]}

Zein, Nizar ^{[2
]}

Mohiuddin, Syed A. ^{[2
]}

机构：

[1] Cleveland Clin Fdn, Dept Internal Med, Cleveland Hts, OH USA

[2] Cleveland Clin, Digest Dis & Surg Inst, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA

来源：

ACG CASE REPORTS JOURNAL | 2025年 / 12卷 / 05期

关键词：

tacrolimus induced acute pancreatitis; drug induced acute pancreatitis; DIP; pancreattiis; tacrolimus; PROFILES;

D O I：

10.14309/crj.0000000000001659

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Tacrolimus-induced acute pancreatitis (TAP) is rare and requires thorough evaluation, including genetic testing, to rule out other causes. While TAP has been documented in a few cases following kidney transplantation, we report the first case of TAP in an adult after liver transplantation, with a noteworthy feature of late-onset TAP occurring more than 12 months after initiating tacrolimus therapy. This case highlights the potential for delayed onset of TAP, and we suggest that tacrolimus may warrant reclassification from category III to Ic in the drug-induced pancreatitis classification. In addition, we introduce sirolimus as a viable alternative for immunosuppression following TAP.

引用

页数：5

共 50 条

[21] Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
Terzi, Funda
Ciftci, Mustafa Kemal
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
[22] Tacrolimus-Induced Neurotoxicity in Early Post-Liver Transplant Saudi Patients: Incidence and Risk Factors
Alissa, Dema A.
Alkortas, Delal
Alsebayel, Mohammed
Almasuood, Rawan Abdullah
Aburas, Wejdan
Altamimi, Tahani
Devol, Edward Bentz
Al-jedai, Ahmed H.
ANNALS OF TRANSPLANTATION, 2022, 27
[23] Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus
Fukuda, Mio
Suetsugu, Kimitaka
Tajima, Soichiro
Katsube, Yurie
Watanabe, Hiroyuki
Harada, Noboru
Yoshizumi, Tomoharu
Egashira, Nobuaki
Mori, Masaki
Masuda, Satohiro
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)
[24] Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
Funda Terzi
Mustafa Kemal Ciftci
BMC Complementary Medicine and Therapies, 22
[25] Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients
Tricot, L
Lebbé, C
Pillebout, E
Martinez, F
Legendre, C
Thervet, E
TRANSPLANTATION, 2005, 80 (11) : 1546 - 1549
[26] Tacrolimus-induced pure red cell aplasia in a postrenal transplant patient
Khetan, Prakash
Jaiswal, Sumeet
Khetan, Seema
Balwani, Manish Ramesh
INDIAN JOURNAL OF TRANSPLANTATION, 2019, 13 (01) : 52 - 53
[27] Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant
Solmaz, Soner
Gokgoz, Zafer
Gereklioglu, Cigdem
Yeral, Mahmut
Boga, Can
Ozdogu, Hakan
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (06) : 702 - 703
[28] Recurrence of hepatic artery thrombosis following acute tacrolimus overdose in pediatric liver transplant recipient
Takahashi, S
Sugimoto, K
Hishikawa, S
Mizuta, K
Fujimura, A
Kawarasaki, H
PEDIATRIC TRANSPLANTATION, 2005, 9 (06) : 809 - 812
[29] Establishment of Tacrolimus-Induced Diabetes in Rat Model and Assessment of Clinical Treatments for Post-Transplant Diabetes Mellitus in Liver Transplant Recipients
Niu, Y. J.
Shen, Z. Y.
Xu, C.
Li, C. F.
Liu, X. J.
Teng, Y. Q.
Chen, H.
Li, L.
Cheng, H. M.
Yang, X. M.
Mao, S.
CLINICAL LABORATORY, 2013, 59 (7-8) : 869 - 874
[30] Tacrolimus-induced epilepsy with primary membranous nephropathy A case report
Yang, Yan
Zhang, Lei
Mo, Ying
Ren, Rong
Wang, Fengmei
MEDICINE, 2021, 100 (09) : E24989

← 1 2 3 4 5 →